Multiple immuno-regulatory defects in type-1 diabetes
AUTOR(ES)
Kukreja, Anjli
FONTE
American Society for Clinical Investigation
RESUMO
Susceptibility to immune-mediated diabetes (IMD) in humans and NOD mice involves their inherently defective T cell immunoregulatory abilities. We have followed natural killer (NK) T cell numbers in patients with IMD, both by flow cytometry using mAbs to the characteristic junctions found in the T cell receptors of this cell subtype, and by semiquantitative RT-PCR for the corresponding transcripts. Both before and after clinical onset, the representation of these cells in patients’ PBMCs is reduced. We also report low numbers of resting CD4+ CD25+ T cells in IMD patients, a subset of T cells shown to have important immunoregulatory functions in abrogating autoimmunities in 3-day thymectomized experimental mice. Whereas a biased Th1 to Th2 cytokine profile has been suggested to underlie the pathogenesis of IMD in both species, we found defective production of IFN-γ in our patients after in vitro stimulation of their PBMCs by phorbol-myristate acetate and ionomycin and both IFN-γ and IL-4 deficiencies in Vα24+ NK T–enriched cells. These data suggest that multiple immunoregulatory T (Treg) cell defects underlie islet cell autoimmunity leading to IMD in humans and that these lesions may be part of a broad T cell defect.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=150819Documentos Relacionados
- B-1 cell: the precursor of a novel mononuclear phagocyte with immuno-regulatory properties
- Metabolic syndrome, insulin resistance and cardiovascular disease in type-1 diabetes Mellitus
- The regulatory region of the human plasminogen activator inhibitor type-1 (PAI-1) gene.
- Applicability of the body adiposity index to estimate body fat in adolescents with type-1 diabetes mellitus
- Randomised prospective study for the effect of therapy on residual beta cell function in type-1 diabetes mellitus [ISRCTN70703138]